Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High …

DL Bhatt, EJ Topol… - American heart …, 2004 - Elsevier
BACKGROUND: Clopidogrel is a more potent antiplatelet agent than aspirin, resulting in
greater clinical efficacy in patients with atherothrombotic disease. Furthermore, the …
被引用次数：228 相关文章

[引用][C] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High …

B DL - Am Heart J, 2004 - cir.nii.ac.jp
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk
primary prevention : rationale and design of the Clopidogrel for High Atherothrombotic Risk and …

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High …

DL Bhatt, EJ Topol - American Heart Journal, 2004 - europepmc.org
Background Clopidogrel is a more potent antiplatelet agent than aspirin, resulting in greater
clinical efficacy in patients with atherothrombotic disease. Furthermore, the combination of …

[引用][C] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High …

DL BHATT, EJ TOPOL - The American heart journal, 2004 - pascal-francis.inist.fr
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk
primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk …

[引用][C] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High …

DL Bhatt, EJ Topol… - American Heart …, 2004 - infona.pl
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk
primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk …

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High …

DL Bhatt, EJ Topol - American heart journal, 2004 - pubmed.ncbi.nlm.nih.gov
Background Clopidogrel is a more potent antiplatelet agent than aspirin, resulting in greater
clinical efficacy in patients with atherothrombotic disease. Furthermore, the combination of …

[引用][C] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High …

DL Bhatt, EJ Topol - The American Heart Journal, 2004 - Elsevier Limited

[引用][C] Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High …

DL BHATT, EJ TOPOL - The American heart journal, 2004 - Mosby